🇺🇸 FDA
Patent

US 8987305

2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

granted A61KA61K31/4164A61K31/4178

Quick answer

US patent 8987305 (2,4,5-trisubstituted imidazoles and their use as anti-microbial agents) held by APTOSE BIOSCIENCES INC. expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
APTOSE BIOSCIENCES INC.
Grant date
Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
57
CPC classes
A61K, A61K31/4164, A61K31/4178, A61K31/4184, A61K31/4188